Aurobindo arm CuraTeQ reports positive Phase 3 results for allergy drug BP11

Aurobindo Pharma gets USFDA approval for Glycerol Phenylbutyrate oral liquid

Aurobindo Pharma Ltd. has received final approval from the US Food and Drug Administration (USFDA) for Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, the company announced on Friday, April 17. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug, Ravicti Oral Liquid, of Horizon Therapeutics U.S. Holding LLC. The company…

Read More
Sanjeev Prasad says 18% Nifty earnings growth intact for FY27, but prolonged conflict a risk

Sanjeev Prasad says 18% Nifty earnings growth intact for FY27, but prolonged conflict a risk

Sanjeev Prasad, Managing Director and Co-Head at Kotak Institutional Equities, believes the Indian equity market may be holding steady for now, but the outlook is increasingly tied to global factors—especially oil prices and geopolitical tensions. He sees the current situation as manageable, but only if disruptions remain short-lived. A prolonged conflict, particularly one that keeps…

Read More
Motilal Oswal’s Khemka favors HDFC Life, NMDC; bullish on metals, power, EMS

Motilal Oswal’s Khemka favors HDFC Life, NMDC; bullish on metals, power, EMS

Siddhartha Khemka, Head of Research, Wealth Management at Motilal Oswal Financial Services, highlighted mixed sector trends, with caution on discretionary and select stocks, while maintaining a positive stance on insurance, mining and industrial segments. He sees earnings visibility improving in select pockets, supported by demand trends, policy tailwinds and sector-specific drivers across commodities, energy and…

Read More
Adding bitcoin alongside gold to your portfolio juiced returns and didn't raise risk, study shows

Adding bitcoin alongside gold to your portfolio juiced returns and didn’t raise risk, study shows

Citi study finds a 5% allocation split between gold and bitcoin boosts portfolio efficiency versus a traditional 60/40 mix, with bitcoin outperforming gold recently. A mix of both gold and bitcoin increased the efficiency of a bond-and-equity portfolio over the last 10 years, according to a study by Citi. Continue Reading with CNBC-TV18 Access Membership…

Read More